Recently, Technical Support Manager and Application Expert, Wilfried Goetz and After-sales Service Manager Daniel Bammes of Xstrahl, manufacturer of the SARRP Small Animal Radiotherapy Research Platform , were invited by China Gate Scientific, the general agent in China, to provide customers with a two weeks of technical support and training.
During their visit, Wilfried and Daniel provided equipment maintenance and technical training to experts from Shanghai Chest Hospital, Shandong Cancer Hospital, Zhejiang Cancer Hospital, and Shanghai Cancer Hospital. This assistance aimed to help customers enhance their research capabilities and output in tumor-related studies using the SARRP small animal radiation research platform.
Wilfried, Daniel, and China Gate Scientific team are unanimously recognized by the researchers
Wilfried's lecture at China Medical University, titled "Application of Small Animal Precision Radiotherapy Technology in Translational Cancer Research," received wide acclaim and praise from experts and scholars.
Wilfried giving lecture at China Medical University
Wilfried and Daniel working in the laboratory
SARRP is a multifunctional radiation therapy platform widely used in small animal research. Its technical advantages are well-suited for small-scale animal studies. SARRP supports advanced research on single or multiple animals, generating images of up to five animals at multiple sites with CT imaging. With high-resolution CT imaging, dynamic bed and gantry motion, it assists in both simple and complex arc treatments. Its intuitive treatment planning software and expert customer support make it superior to other similar systems.
China Gate Scientific has always been dedicated to meeting customer needs and achieving customer satisfaction. We actively organize relevant training sessions, workshops, and academic exchanges to promote efficient and rapid development in the field of scientific research. As the exclusive partner of SARRP in China, we will continue to provide high-quality technical support to our Chinese customers, contributing to the efficient and rapid development of cancer research in China.